Children and adolescents Pharmacokinetic data from fasting children and adolescents (age range 7 - 14 years) with essential thrombocythaemia indicate that dose and body weight normalised exposure, Cmax and AUC, of anagrelide were lower in children/ adolescents compared to adults.